Trials / Completed
CompletedNCT01946009
A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Fundacion SEIMC-GESIDA · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cidofovir could be an effective drug for the treatment of Anal Intraepithelial Neoplasia(AIN).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks. |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2013-09-19
- Last updated
- 2016-06-29
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01946009. Inclusion in this directory is not an endorsement.